TVLine Items: Breaking Bad Actor Gets Switched at Birth, Arrow Targets Heroes Alum and More

TVLine.com

View photo

.
RJ Mitte Switched at Birth
RJ Mitte is going from Breaking Bad to wholesome and good with a role on ABC Family’s Switched at Birth, TVLine has confirmed.

Series creator Lizzy Weiss tweeted the news on Thursday, and the network is now confirming the specifics: He’ll recur in the show’s upcoming third season as Campbell, a pre-med college student paralyzed by a snowboarding accident who works at the free clinic with Daphne (Katie Leclerc).

Ready for more of today’s TV dish? Well…

• The Following has tapped Tony-nominated actress Montego Glover (Memphis), whose TV credits include Smash, The Good Wife and White Collar, to recur in Season 2 as new FBI analyst Lawrence, TVLine has learned exclusively.

 Jimmy Jean-Louis (aka Heroes‘ The Haitian) has booked a multi-episode arc on The CW’s Arrow, ComicBookResources.com reports, as “The Captain,” a deadly cohort of the Dr. Anthony Ivo character being played by Dylan Neal. Both characters will have a tie to a Season 2 mystery called “Amazo” — as in the DC Comics’ infamous android?

• Homeland alum David Harewood will co-star opposite Brendan Gleeson in HBO’s The Money, a drama pilot from David Milch (NYPD Blue, Luck). The project centers on the wealth and corruption surrounding mega-mogul James Castman (Gleeson). Harewood joins as the CEO of the parent company to Castman’s holdings. Andrea Riseborough (Oblivion) has also boarded the project.

The CW is developing Exp, a high school drama from Heroes creator Tim Kring. Per Deadline, the project chronicles the aftermath of a foreign drug – designed to make you faster, smarter, stronger and essentially better – being let loose illegally in American high schools.

Go On‘s Julie White has booked a major recurring role in Nurse Jackie‘s sixth season, The Hollywood Reporter confirms. She’ll play the leading lady’s new AA sponsor.

Which TVLine Items have you talking today?


Get more from TVLine.com: Follow us on Twitter, Facebook, Newsletter

View Comments